Another study found that a high-density ECM utilizes TGF-β signaling to reduce T cell proliferation and alter their differentiation, favoring regulatory over cytotoxic T cells, which impairs the immune function to kill cancer cells [62]. Here, TGFB1 is linked to cancer.